Next Article in Journal
On Interlayer Stability and High-Cycle Simulator Performance of Diamond-Like Carbon Layers for Articulating Joint Replacements
Next Article in Special Issue
Brain Metastases from Lung Cancer Show Increased Expression of DVL1, DVL3 and Beta-Catenin and Down-Regulation of E-Cadherin
Previous Article in Journal
Mass Spectrometry Methodology in Lipid Analysis
Previous Article in Special Issue
SPECT and PET Serve as Molecular Imaging Techniques and in Vivo Biomarkers for Brain Metastases
Int. J. Mol. Sci. 2014, 15(6), 10508-10526; doi:10.3390/ijms150610508

MicroRNAs in Brain Metastases: Potential Role as Diagnostics and Therapeutics

, 1,2
 and 1,2,3,*
Received: 16 April 2014; in revised form: 22 May 2014 / Accepted: 6 June 2014 / Published: 11 June 2014
(This article belongs to the Special Issue Brain Metastasis 2014)
View Full-Text   |   Download PDF [1439 KB, uploaded 19 June 2014]   |   Browse Figures
Abstract: Brain metastases remain a daunting adversary that negatively impact patient survival. Metastatic brain tumors affect up to 45% of all cancer patients with systemic cancer and account for ~20% of all cancer-related deaths. A complex network of non-coding RNA molecules, microRNAs (miRNAs), regulate tumor metastasis. The brain micro-environment modulates metastatic tumor growth; however, defining the precise genetic events that promote metastasis in the brain niche represents an important, unresolved problem. Understanding these events will reveal disease-based targets and offer effective strategies to treat brain metastases. Effective therapeutic strategies based upon the biology of brain metastases represent an urgent, unmet need with immediate potential for clinical impact. Studies have demonstrated the ability of miRNAs to distinguish normal from cancerous cells, primary from secondary brain tumors, and correctly categorize metastatic brain tumor tissue of origin based solely on miRNA profiles. Interestingly, manipulation of miRNAs has proven effective in cancer treatment. With the promise of reduced toxicity, increased efficacy and individually directed personalized anti-cancer therapy, using miRNA in the treatment of metastatic brain tumors may prove very useful and improve patient outcome. In this review, we focus on the potential of miRNAs as diagnostic and therapeutic targets for the treatment of metastatic brain lesions.
Keywords: brain metastases; miRNA replacement therapy; antagomirs brain metastases; miRNA replacement therapy; antagomirs
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |

MDPI and ACS Style

Alsidawi, S.; Malek, E.; Driscoll, J.J. MicroRNAs in Brain Metastases: Potential Role as Diagnostics and Therapeutics. Int. J. Mol. Sci. 2014, 15, 10508-10526.

AMA Style

Alsidawi S, Malek E, Driscoll JJ. MicroRNAs in Brain Metastases: Potential Role as Diagnostics and Therapeutics. International Journal of Molecular Sciences. 2014; 15(6):10508-10526.

Chicago/Turabian Style

Alsidawi, Samer; Malek, Ehsan; Driscoll, James J. 2014. "MicroRNAs in Brain Metastases: Potential Role as Diagnostics and Therapeutics." Int. J. Mol. Sci. 15, no. 6: 10508-10526.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert